VanEck Biotech ETF Rating $168.33 +2.68 (+1.62%) Closing price 09/5/2025 03:58 PM EasternExtended Trading$168.36 +0.02 (+0.01%) As of 09/5/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.68Holdings in BBH have an aggregate rating of Moderate Buy based on 494 analyst ratings issued in the past year covering 24 companies (100.0% of the portfolio).BBH Aggregate Price Target$168.33High Prediction$168.33Average Prediction$168.33Low Prediction$168.33Holdings in BBH have an aggregate price target of $168.33 and a range of $168.33 to $168.33 covering 24 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.35%AMGNAmgen$283.64+1.3%4.7381 of 5 stars2.32$304.43 7.3%22Positive NewsAnalyst Forecast12.84%GILDGilead Sciences$115.05+2.0%4.9537 of 5 stars2.88$115.39 0.3%26Positive News8.69%VRTXVertex Pharmaceuticals$396.12-0.2%4.9696 of 5 stars2.56$497.10 25.5%27Positive NewsAnalyst Forecast6.54%ALNYAlnylam Pharmaceuticals$452.00-0.3%3.8086 of 5 stars2.85$417.38 -7.7%26Trending NewsAnalyst ForecastAnalyst Revision5.36%ARGXargenex$750.78+2.3%4.0027 of 5 stars3.09$772.84 2.9%23Positive NewsAnalyst Forecast5.35%REGNRegeneron Pharmaceuticals$573.38+1.1%4.7396 of 5 stars2.82$817.67 42.6%28Positive NewsAnalyst Upgrade4.87%IQVIQVIA$187.75+2.0%4.9573 of 5 stars2.74$229.86 22.4%23News CoveragePositive NewsAnalyst Forecast4.41%INSMInsmed$145.10+1.8%3.5632 of 5 stars2.94$134.79 -7.1%17Trending NewsAnalyst ForecastInsider TradeAnalyst Revision4.06%NTRANatera$168.02+0.9%3.2562 of 5 stars3.06$194.00 15.5%18News CoveragePositive NewsAnalyst ForecastInsider Trade3.56%ICLRIcon$174.88-0.8%4.2209 of 5 stars2.83$219.64 25.6%18News CoverageAnalyst Forecast3.50%BIIBBiogen$140.67+0.5%4.7685 of 5 stars2.34$185.74 32.0%32Trending NewsAnalyst Forecast3.24%ONCBeOne Medicines$341.80+7.2%1.233 of 5 stars3.00$330.89 -3.2%7Analyst DowngradeGap Up2.87%ILMNIllumina$98.93+1.3%4.8806 of 5 stars2.21$123.06 24.4%19News CoveragePositive NewsAnalyst Forecast2.84%BNTXBioNTech$112.46+8.7%2.196 of 5 stars2.76$135.80 20.8%17News CoverageGap UpHigh Trading Volume2.82%NBIXNeurocrine Biosciences$144.10+2.6%4.7113 of 5 stars2.86$160.00 11.0%21Positive NewsAnalyst ForecastShort Interest ↑2.41%INCYIncyte$86.64+1.4%4.6141 of 5 stars2.33$82.53 -4.7%18Positive NewsAnalyst ForecastShort Interest ↑2.05%MRNAModerna$25.14+3.5%4.4262 of 5 stars2.04$42.88 70.6%24Options Volume1.71%TECHBio-Techne$54.41+2.8%4.9892 of 5 stars2.77$70.42 29.4%13Positive NewsAnalyst Forecast1.63%QGENQiagen$47.54+1.1%4.6689 of 5 stars2.27$49.69 4.5%111.51%CRLCharles River Laboratories International$164.00+1.0%4.0805 of 5 stars2.27$175.69 7.1%15Positive NewsShort Interest ↑1.48%BMRNBioMarin Pharmaceutical$57.77+1.8%4.9805 of 5 stars2.72$93.43 61.7%25News CoveragePositive NewsAnalyst Forecast1.27%EXASExact Sciences$53.81+4.7%4.7303 of 5 stars2.88$67.05 24.6%24News CoverageAnalyst DowngradeShort Interest ↑1.23%RGENRepligen$124.56+3.3%4.7897 of 5 stars2.73$169.55 36.1%11News CoveragePositive NewsAnalyst Forecast0.38%SRPTSarepta Therapeutics$18.71+1.4%4.7591 of 5 stars2.07$43.50 132.5%29Positive News This page (NASDAQ:BBH) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBH Stock Alerts